BioHealth News
Maryland Stem Cell Research Commission Announces $15.4 Million in Awards to Accelerate Cures
48 scientists receive funding from the Maryland Stem Cell Research Fund to further research COLUMBIA, Md. (May 14, 2024)—The Maryland Stem Cell Research Commission…
Read More
NextStep Robotics Wins Pitch Dingman Competition Grand Prize, Announces New Board Members
BALTIMORE, MD – May 13, 2024 – NextStep Robotics, a University of Maryland, Baltimore (UMB) spinout company dedicated to commercializing cutting-edge stroke rehabilitation technologies,…
Read More
Linshom Medical Chosen by the NIH to Attend the Angel Capital Association Annual Meeting
BALTIMORE, MD, US, May 10, 2024 - Linshom Medical, a Maryland based start-up medical device company was selected as one of eight companies to represent…
Read More
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
GAITHERSBURG, Md., May 10, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi…
Read More
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
REDWOOD CITY, Calif. & SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates…
Read More
Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
WASHINGTON, May 9, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator ("Danaher"), today launched a collaboration with Johns Hopkins University aiming to develop…
Read More
Welldoc Named “Best Overall Digital Health Company” for Second Consecutive Year in the 8th Annual MedTech Breakthrough Awards Program
COLUMBIA, Md., May 9, 2024 — Welldoc®, a leading digital health company specializing in cardiometabolic health, today announced that it has been selected as winner of the “Best Overall…
Read More
Stem Cell Research Shines at Maryland Stem Cell and Regenerative Medicine Tech Showcase
COLUMBIA, MD (May 8, 2024) – Maryland’s leading edge in stem cell research was on full display at the Maryland Stem Cell and Regenerative…
Read More
Caring Cross and ImmunoAdoptive Cell Therapy (ImmunoACT) Announce Agreement to Commercialize TriCAR-T Cell Immunotherapy for Leukemia and Lymphoma
Agreement allows ImmunoACT to develop and commercialize a novel TriCAR-T cell therapy for leukemia and lymphoma designed to decrease lapses seen in current single…
Read More
NIH Entrepreneurship Bootcamp
The NIH Entrepreneurship Bootcamp is designed to equip life science investigators and nascent companies with specialized innovation and entrepreneurship training. The course requires no…
Read More
Meet with… Johnson & Johnson’s Immunology Team on May 21st
Join us for Meet With…Johnson & Johnson’s Immunology Team at JLABS @ Washington, DC on May 21.During Digestive Disease Week 2024, our Johnson &…
Read More
Washington DC’s Nanochon closes $4M Series Seed Prime
WASHINGTON--(BUSINESS WIRE)--Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round. The round was led…
Read More
Publication Announcement: Welldoc Shares Clinical Research on AI and Weight Management
welldoc® recently presented a new clinical research paper at the 14th annual Conference on Health IT and Analytics (CHITA) in Washington, D.C. This research…
Read More
Bethesda’s AsclepiX Therapeutics Completes Enrollment in DISCOVER Trial for Neovascular Age-Related Macular Degeneration (nAMD)
BETHESDA, Md., May 06, 2024 (GLOBE NEWSWIRE) -- AsclepiX Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging computational biology from Johns Hopkins to identify and…
Read More
Rockville’s GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced topline…
Read More